ROMANO, ELOISA
 Distribuzione geografica
Continente #
NA - Nord America 2.447
EU - Europa 1.485
AS - Asia 432
AF - Africa 1
Continente sconosciuto - Info sul continente non disponibili 1
SA - Sud America 1
Totale 4.367
Nazione #
US - Stati Uniti d'America 2.441
PL - Polonia 501
IT - Italia 271
IE - Irlanda 248
SE - Svezia 200
CN - Cina 132
HK - Hong Kong 128
RU - Federazione Russa 123
SG - Singapore 69
JO - Giordania 45
FI - Finlandia 34
GB - Regno Unito 32
IN - India 25
DE - Germania 22
VN - Vietnam 18
CH - Svizzera 12
BE - Belgio 11
UA - Ucraina 11
KR - Corea 8
ES - Italia 7
CA - Canada 6
TR - Turchia 6
LU - Lussemburgo 4
FR - Francia 3
NL - Olanda 3
BR - Brasile 1
CZ - Repubblica Ceca 1
DK - Danimarca 1
EU - Europa 1
JP - Giappone 1
RO - Romania 1
TN - Tunisia 1
Totale 4.367
Città #
Warsaw 500
Fairfield 433
Ashburn 245
Chandler 244
Dublin 244
Woodbridge 208
Seattle 177
Houston 161
Cambridge 155
Wilmington 127
Florence 83
Ann Arbor 78
Hong Kong 76
Lawrence 71
Altamura 69
Beijing 62
Princeton 57
Singapore 52
Boston 40
Shanghai 30
San Diego 26
Moscow 21
Boardman 20
Medford 19
Fiesole 17
Milan 17
Pune 17
New York 16
Dong Ket 14
Falls Church 13
Buffalo 12
Jacksonville 12
Kent 12
Hillsboro 11
West Jordan 10
Brussels 7
Castelliri 7
London 7
Sesto Fiorentino 7
Andover 6
Bern 6
Izmir 6
Seoul 6
Toronto 6
Lappeenranta 5
Redwood City 5
Barcelona 4
Kochi 4
Norwalk 4
Rome 4
Scandicci 4
Shenzhen 4
Tappahannock 4
Helsinki 3
Kilburn 3
Louvain-la-Neuve 3
Nanjing 3
Phoenix 3
Washington 3
Camerino 2
Catania 2
Chengdu 2
Forest City 2
Gazzo 2
Genoa 2
Latina 2
Llagostera 2
Los Angeles 2
Monmouth 2
North Bergen 2
Padova 2
Prato 2
Rui'an 2
Saint-Fons 2
Salerno 2
Scarperia e San Piero 2
Sparks 2
Thrissur 2
Tianjin 2
Wallisellen 2
Wuxi 2
Yongin-si 2
Acton 1
Ancona 1
Arnsberg 1
Brno 1
Bucharest 1
Chiswick 1
Copenhagen 1
Dearborn 1
Fara Gera d'Adda 1
Frankfurt am Main 1
Fremont 1
Gravesend 1
Grevenbroich 1
Groningen 1
Guangzhou 1
Hamm 1
Hefei 1
Krakow 1
Totale 3.527
Nome #
Plexin-D1/Semaphorin 3E pathway may contribute to dysregulation of vascular tone control and defective angiogenesis in systemic sclerosis 222
Angiogenic T cell expansion correlates with severity of peripheral vascular damage in systemic sclerosis 210
Decreased expression of the endothelial cell-derived factor EGFL7 in systemic sclerosis: potential contribution to impaired angiogenesis and vasculogenesis 193
Clinical, instrumental, serological and histological findings suggest that hemophilia B may be less severe than hemophilia A 148
Proangiogenic effects of soluble α-Klotho on systemic sclerosis dermal microvascular endothelial cells 120
Decreased expression of neuropilin-1 as a novel key factor contributing to peripheral microvasculopathy and defective angiogenesis in systemic sclerosis 120
TNF-α/TNF-R System May Represent a Crucial Mediator of Proliferative Synovitis in Hemophilia A 113
Endothelial-to-mesenchymal transition contributes to endothelial dysfunction and dermal fibrosis in systemic sclerosis 110
Agonistic anti-human Fas monoclonal antibody induces fibroblast-like synoviocyte apoptosis in haemophilic arthropathy: potential therapeutic implications 106
Differential expression of junctional adhesion molecules in different stages of systemic sclerosis 106
Decrease of LL-37 in systemic sclerosis: a new marker for interstitial lung disease? 98
Bone marrow-derived mesenchymal stem cells from early diffuse systemic sclerosis exhibit a paracrine machinery and stimulate angiogenesis in vitro 97
Angiotensin II type 2 receptor (AT2R) as a novel modulator of inflammation in rheumatoid arthritis synovium 97
Systemic Sclerosis Serum Steers the Differentiation of Adipose-Derived Stem Cells Toward Profibrotic Myofibroblasts: Pathophysiologic Implications 96
The IL1-like cytokine IL33 and its receptor ST2 are abnormally expressed in the affected skin and visceral organs of patients with systemic sclerosis 93
Neuropeptides activate TRPV1 in rheumatoid arthritis fibroblast-like synoviocytes and foster IL-6 and IL-8 production. 90
Increased serum levels and tissue expression of matrix metalloproteinase-12 in patients with systemic sclerosis: correlation with severity of skin and pulmonary fibrosis and vascular damage 88
Evidence for a Derangement of the Microvascular System in Patients with a Very Early Diagnosis of Systemic Sclerosis 85
Enthesopathy and involvement of synovio-entheseal complex in systemic sclerosis: an ultrasound pilot study 84
A two-step immunomagnetic microbead-based method for the isolation of human primary skin telocytes/CD34+ stromal cells 83
Progressive loss of lymphatic vessels in skin of patients with systemic sclerosis 80
Disease Activity Improvement in Rheumatoid Arthritis Treated with Tumor Necrosis Factor-α Inhibitors Correlates with Increased Soluble Fas Levels. 78
Overexpression of VEGF165b, an inhibitory splice variant of vascular endothelial growth factor, leads to insufficient angiogenesis in patients with systemic sclerosis 76
Glycolysis-derived acidic microenvironment as a driver of endothelial dysfunction in systemic sclerosis 75
Overexpression of VEGF165b, an inhibitory splice variant of vascular endothelial growth factor, leads to insufficient angiogenesis in patients with systemic sclerosis 74
Vascular biomarkers and correlation with peripheral vasculopathy in systemic sclerosis 73
Slit2/Robo4 axis may contribute to endothelial cell dysfunction and angiogenesis disturbance in systemic sclerosis 73
Decreased circulating lymphatic endothelial progenitor cells in digital ulcer-complicated systemic sclerosis 70
Increased plasma levels of the VEGF165b splice variant are associated with the severity of nailfold capillary loss in systemic sclerosis 69
The contribution of mesenchymal transitions to the pathogenesis of systemic sclerosis 65
Systemic Sclerosis Serum Significantly Impairs the Multi-Step Lymphangiogenic Process: in Vitro Evidence 63
THE CROSSTALK OF THE SKIN-ORAL-GUT MICROBIOME AXIS IN LIMITED AND DIFFUSE CUTANEOUS SYSTEMIC SCLEROSIS 63
Stiff Skin Syndrome 62
STIMULATION OF SOLUBLE GUANYLATE CYCLASE (sGC) FOSTERS ANGIOGENESIS AND BLUNTS ENDOTHELIAL-TO-MESENCHYMAL TRANSITION (EndoMT) OF SYSTEMIC SCLEROSIS (SSc) DERMAL MICROVASCULAR ENDOTHELIAL CELLS 59
Evidence for caveolin-1 as a new susceptibility gene regulating tissue fibrosis in systemic sclerosis. 57
The contribution of epigenetics to the pathogenesis and gender dimorphism of systemic sclerosis: a comprehensive overview 57
Increased circulating levels of interleukin 33 in systemic sclerosis correlate with early disease stage and microvascular involvement 56
The Role of Pro-fibrotic Myofibroblasts in Systemic Sclerosis: From Origin to Therapeutic Targeting 56
Adipose-derived stem cells: Pathophysiologic implications vs therapeutic potential in systemic sclerosis 53
A candidate gene study reveals association between a variant of the SRp55 splicing factor gene and systemic sclerosis 50
Decreased expression of the endothelial cell-derived factor EGFL7 contributes to impaired angiogenesis and vasculogenesis in systemic sclerosis 42
The Soluble Guanylate Cyclase Stimulator BAY 41-2272 Attenuates Transforming Growth Factor β1-Induced Myofibroblast Differentiation of Human Corneal Keratocytes 40
Bosentan blocks the antiangiogenic effects of sera from systemic sclerosis patients: an in vitro study 40
Extracellular lactic acidosis drives reprogramming of human subcutaneous adipocytes toward pathogenic myofibroblasts 39
A new avenue in the pathogenesis of systemic sclerosis: the molecular interface between the endothelial and the nervous systems 39
Oral lactobacillus species in systemic sclerosis 39
The contribution of endothelial cells to tissue fibrosis 37
FAS/FASL and TF/FVII Levels In Rheumatoid Arthritis Patients Treated With TNF Antagonists 37
Scleroderma-like Impairment in the Network of Telocytes/CD34+ Stromal Cells in the Experimental Mouse Model of Bleomycin-Induced Dermal Fibrosis 35
POS0613 THE ROLE OF MICROBIOTA IN DIFFERENT DISEASE STAGES OF SYSTEMIC SCLEROSIS: A POSSIBLE IMPACT IN GASTROINTESTINAL TRACT DISEASE ACTIVITY? 34
Impairment in the telocyte/CD34+ stromal cell network in human rheumatoid arthritis synovium 34
Circulating Neurovascular Guidance Molecules and Their Relationship with Peripheral Microvascular Impairment in Systemic Sclerosis 33
New Insights into Profibrotic Myofibroblast Formation in Systemic Sclerosis: When the Vascular Wall Becomes the Enemy 33
Decreased Serum Levels of SIRT1 and SIRT3 Correlate with Severity of Skin and Lung Fibrosis and Peripheral Microvasculopathy in Systemic Sclerosis 33
POS1593-HPR GASTROINTESTINAL INVOLVEMENT IS ALREADY REPORTED IN AN ITALIAN VEDOSS COHORT: RESULTS FROM A RHEUMATOLOGICAL NURSE ASSESSMENT 33
Soluble guanylate cyclase stimulation fosters angiogenesis and blunts myofibroblast-like features of systemic sclerosis endothelial cells 29
The authors' reply 29
Soluble guanylate cyclase stimulation fosters angiogenesis and blunts myofibroblast-like features of scleroderma endothelial cells 27
The differential crosstalk of the skin-gut microbiome axis as a new emerging actor in systemic sclerosis 25
Extracellular Lactic Acidosis of the Tumor Microenvironment Drives Adipocyte-to-Myofibroblast Transition Fueling the Generation of Cancer-Associated Fibroblasts 23
Advances in Systemic Sclerosis: From Pathogenetic Pathways toward Novel Therapeutic Targets 23
The genetics of systemic sclerosis: an update. 23
Immunohistochemical and ultrastructural identification of telocytes in the lamina propria of human vaginal mucosa 22
Increased Circulating Soluble Junctional Adhesion Molecules in Systemic Sclerosis: Association with Peripheral Microvascular Impairment 22
ORAL MICROBIOME IN RHEUMATIC DISEASES.WHAT INVOLVEMENT? 18
Current Trends in Vascular Biomarkers for Systemic Sclerosis: A Narrative Review 15
Lymphatic Endothelial-to-Myofibroblast Transition: A Potential New Mechanism Underlying Skin Fibrosis in Systemic Sclerosis 14
Blockade of Sialylation with Decrease in Polysialic Acid Levels Counteracts Transforming Growth Factor β1-Induced Skin Fibroblast-to-Myofibroblast Transition 14
Autoantibodies as putative biomarkers and triggers of cell dysfunctions in systemic sclerosis 13
Pharmacological Stimulation of Soluble Guanylate Cyclase Counteracts the Profibrotic Activation of Human Conjunctival Fibroblasts 12
The differential crosstalk of the skin–gut microbiome axis as a new emerging actor in systemic sclerosis 8
Recent Insights into Cellular and Molecular Mechanisms of Defective Angiogenesis in Systemic Sclerosis 8
null 2
Totale 4.543
Categoria #
all - tutte 16.238
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 16.238


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020857 0 50 24 72 100 116 105 111 105 77 86 11
2020/2021749 47 61 35 111 30 58 63 50 83 125 39 47
2021/2022361 14 10 19 12 23 33 7 12 34 23 51 123
2022/20231.132 104 235 43 79 56 196 163 49 125 11 37 34
2023/2024594 14 60 85 31 46 81 36 112 10 33 41 45
2024/2025177 120 57 0 0 0 0 0 0 0 0 0 0
Totale 4.543